First Quarter 2018 Investor Presentation

Financials changing diabetes Investor Presentation First three months of 2018 Slide 97 1. Sales growth 98 2. Operating Profit growth 100 3. Cost distribution 101 4. COGS & CAPEX as percent of sales 102 5. Cash return to shareholders 6. Currency impact 7. Ownership structure novo nordisk 104 105 108

View entire presentation